These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder. Behzatoğlu K. Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380 [Abstract] [Full Text] [Related]
6. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder. Broede A, Oll M, Maurer A, Siegert S, Stoerkel S, Golz R, Schwamborn K, Veeck J, Knuechel R, Gaisa NT, German study group of bladder cancers. J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756 [Abstract] [Full Text] [Related]
11. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder. Bollito ER, Pacchioni D, Lopez-Beltran A, Volante M, Terrone C, Casetta G, Mari M, DePompa R, Cappia S, Papotti M. Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833 [Abstract] [Full Text] [Related]
12. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Shanks JH, Iczkowski KA. Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589 [Abstract] [Full Text] [Related]
18. [Nephrogenic adenoma of the bladder. Morphological and immunophenotypic study with particular attention to differential diagnosis]. Isimbaldi G, Di Nuovo F, Sironi M, Catania G, Bonacina R, Privitera O, Spinelli M. Pathologica; 1999 Jun; 91(3):192-7. PubMed ID: 10536465 [Abstract] [Full Text] [Related]